France’s Rivercell emerges from stealth with €22 million for AI-powered drug discovery infrastructure
Rivercell, a Paris-based BioTech and AI company building proprietary cell-response data infrastructure and a world model that predicts how human cells respond to treatment, has launched today out of stealth with a €22 million ($25 million) Seed round. The round was led by HV, with participation from
<p>Rivercell, a Paris-based BioTech and AI company building proprietary cell-response data infrastructure and a world model that predicts how human cells respond to treatment, has launched today out of stealth with a €22 million ($25 million) Seed round. The round was led by HV, with participation from</p>